Ultomiris is biologic therapy that is indicated for treating
- adult patients with paroxsymal nocturnal hemoglobinuria (PNH)
- adults and pediatric patients one month of age and older with atypical hemolytic uremic syndrome (aHUS)
Ultomiris is also known as Ravulizumab-cwvz.
It is a long-acting C5 inhibitor administered every eight weeks in adults.
Ultomiris works by inhibiting the C5 protein in the terminal complement cascade, which is a biochemical process in the body’s immune system.
Ultomiris is intended to treat paroxsymal nocturnal hemoglobinuria (PNH) in adults and pediatric patients one month of age and older with atypical hemolytic uremic syndrome (aHUS).
Patients choose Red Bank Infusion Center
to have their Ultomiris therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service
Want to move to
Red Bank Infusion Center?
We make it simple and convenient for you to start your infusion care with us.
